AI startup Tavus founder says users talk to its AI Santa ‘for hours’ per day
Tavus has launched a new experience where you can chat with an AI Santa that asks personal questions and remembers your interests.
Figma launches new AI-powered object removal and image extension
Figma is launching a new image editing toolbar to bring all its features in one place.
Petco takes down Vetco website after exposing customers’ personal information
TechCrunch found Petco’s veterinary clinics were spilling customers’ personal information and medical histories of their pets to the open web.
Google launches sub-$5 AI Plus plan in India to compete with ChatGPT Go
For new users in India, Google is offering an AI Plus subscription for ₹199 ($2.21) for the first six months, after which you’ll have to pay ₹399 ($4.44).
Instagram’s new ‘Your Algorithm’ tool gives you more control over the Reels you see
You can select which topics you want to see more or less of, and your recommendations will adapt accordingly.
Adobe brings Photoshop, Express and Acrobat features to ChatGPT
ChatGPT’s 800 million plus userbase can now use Adobe’s apps to modify images and PDFs
Amazon to invest additional $35B in India by 2030, taking total planned spending to $75B
The e-commerce giant said the new investment will support its efforts to digitize small businesses and strengthen its logistics and operations footprint in India.
Google invests in Fervo’s $462M round to unlock even more geothermal energy
Fervo Energy’s Series E round will help the company build additional phases of its Cape Station power plant while beginning development on new sites.
Meesho’s $606M IPO pops as enthusiasm for India’s e-commerce startups rises
Meesho had a good first day as a public company, with its shares climbing as much as 46% from its issue price as investors jumped to grab a piece of the company built around small merchants and value-conscious consumers.
Fertility startup Inito wants to use AI-designed antibodies to expand at-home health tests
Inito has raised $29 million in new funding to invest in and develop AI-engineered antibodies that will help it offer new types of tests and improve the accuracy of existing ones.